ISSN 0975-3583

Journal of Cardiovascular Disease Research

    A tertiary health center's prevalence of non-alcoholic fatty liver disease and metabolic syndrome in psoriasis

    Dr. GS Vikram, Dr. Gorakati Mukunda Reddy
    JCDR. 2022: 1145-1148


    The goal of this research was to examine the incidence of psoriatic fatty liver disease in the south Indian population. Research into the incidence of metabolic syndrome in people with psoriasis in south India. Determine if there is a relationship between psoriasis severity and the incidence of NAFLD. The goal of this study is to determine whether or not age, severity and type of psoriasis are associated with non-alcoholic fatty liver disease and metabolic syndrome. Method: Our study, which included 180 people with psoriasis, is a cross-sectional analysis of the condition conducted at Department of pulmonary medicine, Sri Sathya Sai Medical College and Hospital, Tamil Nadu, India from August 2021 to July 2022. Patients with psoriasis who are using hepatotoxic medicines or who are heavy drinkers will not be included in the trial. All patients undergo a battery of diagnostics, including ultrasonography, after a thorough clinical history and physical examination. Result: In our study, 52.3% of participants with psoriasis also had NAFLD and 18.5% of participants also had metabolic syndrome. Our results also show an increase in the other features of metabolic syndrome. Psoriasis severity is unrelated to non-alcoholic fatty liver disease. Significant dyslipidemia was seen in psoriasis patients with metabolic syndrome. Conclusion: There is a strong correlation between psoriasis, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Psoriasis has been shown to have an independent association with NAFLD.


    » PDF

    Volume & Issue

    Volume 13 Issue 7